RecruitingNot ApplicableNCT06081387
The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment
The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment: the DIAVITEX Project
Sponsor
University Ramon Llull
Enrollment
80 participants
Start Date
Oct 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Eligibility
Min Age: 40 Years
Inclusion Criteria5
- Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
- Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
- Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
- Patients who signed the informed consent
- Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes)
Exclusion Criteria4
- Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
- Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention
- Female subjects who are pregnant
- Patients who did not sign the informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERResistance training
Sarcoplasm stimulating training system. This program will run for a total of 16 weeks and three sessions a week. This exercise plan is designed in three 5-week periods plus a familiarization session.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06081387
Related Trials
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
NCT0711233975 locations
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418122 locations
ROME GS System Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the ROME GS System
NCT075180044 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731151 locations
Autologous SVF Therapy for Type 2 Diabetes
NCT074874671 location